A network of nerves similar to wires runs all through the human body, from the tips of your fingers and toes, through your ...

Suzetrigine (Journavx) is the first non-opioid pain medication to be approved in the US in 20 years. It could help over 80 million Americans living with severe acute pain, while reducing the effects ...

A new type of painkiller aimed at treating pain from an injury or surgery has been approved by the US Food and Drug Administration (FDA). The drug suzetrigine, also known by its brand name Journavx, ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

Curious Kids is a series for children of all ages. If you have a question you'd like an expert to answer, send it to ...

The US Food and Drug Administration (FDA) announced its approval of a non-opioid treatment for moderate–severe acute chronic ...

Researchers studied genetically modified mice that lack NP2 itch-sensing neurons, to investigate the connection between itch, ...

Thursday, February 27, 2025 - 11:00 a.m. to 12:00 p.m.

Migraine is one of the most severe and debilitating brain disorders. Most scientists accept that it involves activation and sensitization of the trigeminovascular system, which includes the ...

The pharmacokinetics, safety, and tolerability of four topical lidocaine patches 5% continuously applied for 72 hours and changed every 12 or 24 hours were examined. In this randomized ...